Feb 23, 2023
XMS Advised Exact Sciences on its $573mm Debt Exchange Transaction and Private Placement of Convertible Senior Notes
Exact Sciences Corp. (Nasdaq: EXAS) (the "Company"), a leading provider of cancer screening and diagnostic tests, today announced that on February 23, 2023 it entered into a privately negotiated exchange and purchase agreement (the "Agreement") with a holder of certain of the Company's 0.3750% Convertible Senior Notes due 2027 (the "Existing 2027 Notes") and certain of its 0.3750% Convertible Senior Notes due 2028 (the "Existing 2028 Notes", and together with the "Existing 2027 Notes", the "Existing Notes").
August 2, 2022
XMS Advised Exact Sciences on the Sale of its Oncotype DX® GPS Prostate Cancer Business to Mdxhealth
MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision diagnostics company, today announced it has entered into an asset purchase agreement with Genomic Health, Inc., a subsidiary of Exact Sciences Corporation ("Exact Sciences"), to acquire the Oncotype DX® GPS (Genomic Prostate Score®) test from Exact Sciences along with most of its team of urology sales and marketing professionals.
July 19, 2022
XMS Advised Unity Aluminum on its Joint Venture Arrangement with Steel Dynamics
Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced that its Board of Directors has authorized the company to construct and operate a 650,000-tonne low-carbon, recycled aluminum flat rolled mill, with two supporting satellite recycled aluminum slab centers. The capital investment is estimated to be $2.2 billion for the three facilities, and commercial production is planned to begin in the first quarter 2025.
Jan 09, 2022
Exact Sciences Acquires PreventionGenetics To Accelerate Availability Of Hereditary Cancer Testing For More Patients
PreventionGenetics' comprehensive genetic testing portfolio complements Exact Sciences' advanced cancer tests, enabling disease prevention and earlier cancer detection to benefit patients across decades of life. Foundational laboratory and skilled team with experience in sequencing, informatics, and genetic counseling will support entrance into hereditary cancer testing
Oct 26, 2021
XMS Serves as Financial Advisor to IAA on its acquisition of SYNETIQ
XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm providing investment banking, asset management and merchant banking services, announced that it served as financial advisor to IAA, Inc. (NYSE: IAA), a leading global digital marketplace connecting vehicle buyers and sellers, on its acquisition of SYNETIQ Ltd. (“SYNETIQ”), a leading integrated salvage and vehicle dismantling company in the United Kingdom, for £225 million.